Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW 4,005.00
+70.00 (1.78%)
Sep 18, 2026, 3:30 PM KST
Bukwang Pharmaceutical Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 215,093 | 200,714 | 160,087 | 125,928 | 190,909 | 182,491 |
Revenue Growth | 20.05% | 25.38% | 27.13% | -34.04% | 4.61% | 7.56% |
Gross Profit Gross Profit Growth | 95,285 | 91,528 | 74,064 | 46,916 | 79,147 | 75,550 |
Operating Income Operating Income Growth | 11,651 | 14,164 | 1,618 | -37,497 | -230.64 | 5,622 |
Net Income Net Income Growth | 8,778 | 12,558 | -2,641 | -31,330 | -2,475 | -916.62 |
Earnings Per Share EPS Growth | 89.79 | 152.00 | -39.00 | -458.00 | -36.15 | -13.39 |
EPS Growth | -23.48% | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Pharmaceutical Growth | 191,394 | 162,684 | 129,486 | 196,932 | 182,491 |
Research and Development Department Research and Development Department Growth | 10,692 | - | - | - | - |
Consolidation Adjustments Consolidation Adjustments Growth | -1,371 | -2,597 | -3,557 | -6,023 | - |
Total Total Growth | 200,714 | 160,087 | 125,928 | 190,909 | 182,491 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 169,096 | 216,208 | 130,091 | 151,227 | 85,517 | 84,277 |
Total Debt Total Debt Growth | 80,667 | 80,341 | 79,424 | 79,387 | 930.79 | 1,558 |
Net Cash (Debt) Net Cash Growth | 88,429 | 135,867 | 50,667 | 71,840 | 84,586 | 82,719 |
Net Cash Growth | 49.01% | 168.16% | -29.47% | -15.07% | 2.26% | 21.57% |
Net Cash Per Share Net Cash Per Share Growth | 904.56 | 1644.73 | 740.15 | 1049.46 | 1235.65 | 1208.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,478 | 21,464 | 34,362 | -9,362 | 16,461 | 26,525 |
Capital Expenditures CapEx Growth | -7,014 | -7,257 | -1,938 | -2,835 | -4,298 | -785.05 |
Free Cash Flow Free Cash Flow Growth | -1,536 | 14,206 | 32,424 | -12,196 | 12,163 | 25,740 |
Free Cash Flow Growth | - | -56.18% | - | - | -52.74% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.30% | 45.60% | 46.27% | 37.26% | 41.46% | 41.40% |
Operating Margin | 5.42% | 7.06% | 1.01% | -29.78% | -0.12% | 3.08% |
Pretax Margin | 3.78% | 3.18% | -1.85% | -31.42% | -0.54% | 2.08% |
Profit Margin | 4.08% | 6.26% | -1.65% | -24.88% | -1.30% | -0.50% |
FCF Margin | -0.71% | 7.08% | 20.25% | -9.69% | 6.37% | 14.11% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Sep '26 Sep 20, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 150.000 | 125.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 3.75% | 3.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 44.61 | 29.74 | - | - | - | - |
Forward PE | - | 58.75 | 58.75 | 58.75 | 58.75 | 58.75 |
P/FCF Ratio | - | 26.29 | 9.69 | - | 49.25 | 34.31 |
PS Ratio | 1.84 | 1.86 | 1.96 | 3.32 | 3.14 | 4.84 |